JNJ — Johnson & Johnson Share News
0.000.00%
Last trade - 00:00- $610.38bn
- $638.66bn
- $94.19bn
Factbox: Global drugmakers invest billions to boost US presence
Factbox: Global drugmakers invest billions to boost US presence
Bristol Myers to build $2.3 billion manufacturing site in Houston
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
The Week in Breakingviews: Wall Street rainstorms
Stryker beats quarterly estimates on strong demand for medical devices
Stryker beats quarterly estimates on strong demand for medical devices
Brief: Johnson & Johnson's Rybrevant Faspro™ (Amivantamab And Hyaluronidase-Lpuj) Receives U.S. FDA Priority Review As Potential First-In-Class Egfr- And Met-Targeted Subcutaneous Treatment For Advanced Head And Neck Cancer
Press Digest: Wall Street Journal - July 30
Brief: Johnson & Johnson Completes Acquisition Of Firefly Bio, Inc. To Advance Next-Generation Oncology Innovation
J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027 (updated)
Johnson & Johnson lowers 2026 profit forecast
Explainer: Can J&J finally put the talc litigation behind it?
Explainer: Can J&J finally put the talc litigation behind it?
U.S. STOCKS ON THE MOVE-Visa, CMS Energy, Ecolab
Big Pharma gets a lesson in trusting the science
U.S. STOCKS ON THE MOVE-Visa, CMS Energy, Ecolab
U.S. STOCKS ON THE MOVE-American Tower, Xylem, Core Scientific
Analysis: Trump's diversity crackdown reverberates through US boardrooms